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Etoricoxib (ETX) is a specific type of an anti-
inflammatory drug most commonly used for the relief of 
pain and swelling suffered by individuals1,2. Chemically it 
is 5-chloro-3-[4-methanesulfonyl phenyl]-2-[6-methyl 
pyridin-3-yl] pyridine3. Literature review revealed very 
few analytical methods including HPLC4, HPTLC5, LC-
MS6, Capillary zone electrophoresis7 and 
Ultraperformance liquid chromatography8 for 
simultaneous determination of etoricoxib  in 
pharmaceutical dosage forms. In the present study 
spectrophotometric method employing acid-dye technique9 
for determination of etoricoxib in pure form and tablets is 
described. The method is based on the formation of a 
charge transfer complex of the drug with an acid-dye, 
whose absorbance is measured at the λmax of the complex, 
after extraction into chloroform.  
MATERIALS AND METHODS: 
Instrumentation:  
All spectral and absorbance measurements were made on 
Shimadzu UV-VIS Spectrophotometer-1650. 
Reagents:  
Chloroform, bromothymolblue solution (0.3%w/v), buffer 
of different pH from 2.2 to 4.0 as per I.P.1996. All 
reagents used were of analytical grade.  
Preparation of standard solution:  
A 1 mg/ml stock solution of ETX was prepared by 
dissolving 100 mg of drug in  100 ml of ethanol. 
Procedure:  
Appropriate aliquots of the standard drug solution were 
pipetted out into a series of eight separating funnels. To 
each funnel 2 ml of buffer and 5 ml of dye solution were 
added and mixed thoroughly. The complex was extracted 
with three successive quantities each of 8 ml of chloroform 
into 25 ml volumetric flask and made upto volume with 
chloroform. The absorbance of the ion-pair complex was 
measured at the λmax of the dye in the solvent against the 
reagent blank. The solutions were scanned in the spectrum 
mode in the wavelength range of 400-800 nm. The  λmax  of 
the complex was found to be 414nm as shown in fig-1.The 
analytical curve was constructed by plotting concentration 
versus absorbance. 
 
Figure 1: λmax of the ion-pair complex of ETX 
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Sample Analysis: 
Twenty tablets were weighed and powdered. A quantity 
equivalent to about 100mg of etoricoxib was weighed 
accurately, transferred to a beaker, disssolved in ethanol, 
filtered through Whatmann filter paper No.1 into 100ml 
volumetric flask and made upto volume with ethanol. 
Appropriate aliquots (within Beer’s law concentration ) 
were subjected to the above procedure and the amount of 
etoricoxib was determined from the calibration curve. The 
results are furnished in Table- 2. 
RESULTS AND DISCUSSION: 
Etoricoxib was found to yield a coloured product with the 
dye bromothymolblue due to the formation of an ion-pair 
complex. The λmax of the etoricoxib complex with 
bromothymol blue was found to be 414nm. The optimum 
pH for the formation of complex was found to be 2.2.  The 
optical characteristics such as absorption maxima, Beer’s 
law limits, molar absorptivity and Sandell’s sensitivity are 
furnished in Table-1. The regression characteristics like 
slope(m), intercept(c), correlation co-efficient(r), percent 
relative standard deviation(% RSD) and standard error(SE) 
were calculated and the results are summarized in Table-1. 
The amount of drug determined was in good agreement 
with the label claim showing the accuracy of the proposed 
method. To study the accuracy and reproducibility of the 
proposed method, recovery experiments were carried out 
by adding a known amount of drug to preanalysed sample 
and the percentage recovery was calculated. The 
percentage of recovery was around 100% proving the 
reproducibility of the method. The results are furnished in 
Table-2. The results indicate that there is no interference of 
other ingredients present in the formulations. 
 
Table 1: Optical and Statistical Parameters 
Parameters  Results 
λmax(nm) 414  
Beer’s law limits(µg/ml)  10-80  
Molar absorptivity(L molˉ¹ cmˉ¹)  359.35  
Sandell’s senstivity(µg/cm²/0.001absorbance unit)  0.00892  
Regression equation(*y)  0.0111x+0.0019 
Slope(m)  0.0111 
Intercept(c)  0.0019  
Correlation co-efficient (r)  0.9998  
%RSD  0.005382  
Standard error(SE)  0.1141  
*y=mx+c, where c is the concentration of ETX in µg/ml 
Table 2: Assay and recovery of ETX in dosage form 
          Drug  Labelled amount (mg)       Amount obtained (mg)*  Percentage  recovery*  
        Etoricoxib           60         60.005       100.03 
*Average of 6 determinations 
CONCLUSION: 
The proposed method is 
simple,economical,sensitive,accurate,reproducible and 
useful for the routine determination of etoricoxib in tablets. 
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